FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004151102> ?p ?o ?g. }

• W2004151102 endingPage "1016" @default.
• W2004151102 startingPage "1003" @default.
• W2004151102 abstract "To review the efficacy of drug therapy for urinary urge incontinence by examining the published literature.In October 1999, we searched the medical databases MEDLINE, EMBASE, and Cochrane Controlled Trials Register to identify prospective randomized, double-blind, placebo-controlled clinical trials in the English literature evaluating drug therapy (except hormonal therapy) of urinary urge incontinence. Trials were categorized by type of drug and outcome variables.Forty-seven trials were identified. Twenty-four, 12, and 11 trials evaluated anticholinergic drugs, drugs with anticholinergic and calcium antagonistic properties, and alternative regimens, respectively. Data regarding treatment effects of anticholinergic drugs are consistent with a high therapeutic efficacy and characteristic side effects. Therapeutic efficacy and side effect patterns of terodiline, an agent with anticholinergic and calcium antagonistic properties, were comparable to those of anticholinergic agents. Terodiline, however, has been withdrawn from the market because of its association with cardiac arrhythmia. Of the investigated alternative drug regimens, the papaverine-like smooth muscle relaxant flavoxate was reported to be ineffective. Studies investigating the dopamine agonist bromocryptine, the alpha-adrenoceptor blocker prazosin, or the gamma-aminobutyric acid receptor agonist baclofen showed subjective and/or objective improvement of symptoms without reaching statistical significance, whereas the tricyclic antidepressant doxepin, the neurotoxin capsaicin, and the prostaglandin synthase inhibitor flurbiprofen led to statistically significant subjective and/or objective improvement of symptoms. No data for subjective and/or objective improvement of symptoms could be extracted from the studies using the anticholinergic and calcium antagonistic agent propiverine and the calcium antagonist thiphenamil.Published trials support anticholinergic drugs as efficacious therapy for urinary urge incontinence, with predictable side effects. At present, these agents represent the pharmacological treatment of choice for this condition. The potential value of selected alternative drugs is underscored by the available data." @default.
• W2004151102 created "2016-06-24" @default.
• W2004151102 creator A5014109887 @default.
• W2004151102 creator A5016318953 @default.
• W2004151102 creator A5019177429 @default.
• W2004151102 creator A5077806577 @default.
• W2004151102 creator A5080975285 @default.
• W2004151102 date "2002-11-01" @default.
• W2004151102 modified "2023-10-17" @default.
• W2004151102 title "Drug therapy of urinary urge incontinence: a systematic review" @default.
• W2004151102 cites W104464120 @default.
• W2004151102 cites W1410775549 @default.
• W2004151102 cites W1964293954 @default.
• W2004151102 cites W1965756679 @default.
• W2004151102 cites W1967031158 @default.
• W2004151102 cites W1972586046 @default.
• W2004151102 cites W1977586210 @default.
• W2004151102 cites W1986053715 @default.
• W2004151102 cites W1993486897 @default.
• W2004151102 cites W1996684801 @default.
• W2004151102 cites W1999475981 @default.
• W2004151102 cites W2005791359 @default.
• W2004151102 cites W2024975356 @default.
• W2004151102 cites W2028811068 @default.
• W2004151102 cites W2042777224 @default.
• W2004151102 cites W2043721744 @default.
• W2004151102 cites W2046337606 @default.
• W2004151102 cites W2050020151 @default.
• W2004151102 cites W2052664268 @default.
• W2004151102 cites W2053004433 @default.
• W2004151102 cites W2057187748 @default.
• W2004151102 cites W2060110594 @default.
• W2004151102 cites W2072187682 @default.
• W2004151102 cites W2072264743 @default.
• W2004151102 cites W2073696965 @default.
• W2004151102 cites W2082617454 @default.
• W2004151102 cites W2083510953 @default.
• W2004151102 cites W2085143860 @default.
• W2004151102 cites W2086148792 @default.
• W2004151102 cites W2088087567 @default.
• W2004151102 cites W2094789282 @default.
• W2004151102 cites W2104305709 @default.
• W2004151102 cites W2121173491 @default.
• W2004151102 cites W2121811192 @default.
• W2004151102 cites W2127252378 @default.
• W2004151102 cites W2152791010 @default.
• W2004151102 cites W2167728530 @default.
• W2004151102 cites W2169544570 @default.
• W2004151102 cites W2280150101 @default.
• W2004151102 cites W2296978143 @default.
• W2004151102 cites W2327894593 @default.
• W2004151102 cites W23475249 @default.
• W2004151102 cites W2395944810 @default.
• W2004151102 cites W2409422291 @default.
• W2004151102 cites W2413247061 @default.
• W2004151102 cites W2414785844 @default.
• W2004151102 cites W2418584879 @default.
• W2004151102 cites W2730304003 @default.
• W2004151102 doi "https://doi.org/10.1016/s0029-7844(02)02238-x" @default.
• W2004151102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12423868" @default.
• W2004151102 hasPublicationYear "2002" @default.
• W2004151102 type Work @default.
• W2004151102 sameAs 2004151102 @default.
• W2004151102 citedByCount "31" @default.
• W2004151102 countsByYear W20041511022017 @default.
• W2004151102 countsByYear W20041511022022 @default.
• W2004151102 countsByYear W20041511022023 @default.
• W2004151102 crossrefType "journal-article" @default.
• W2004151102 hasAuthorship W2004151102A5014109887 @default.
• W2004151102 hasAuthorship W2004151102A5016318953 @default.
• W2004151102 hasAuthorship W2004151102A5019177429 @default.
• W2004151102 hasAuthorship W2004151102A5077806577 @default.
• W2004151102 hasAuthorship W2004151102A5080975285 @default.
• W2004151102 hasConcept C126322002 @default.
• W2004151102 hasConcept C126894567 @default.
• W2004151102 hasConcept C142724271 @default.
• W2004151102 hasConcept C204787440 @default.
• W2004151102 hasConcept C27081682 @default.
• W2004151102 hasConcept C2778531004 @default.
• W2004151102 hasConcept C2778689640 @default.
• W2004151102 hasConcept C2910745098 @default.
• W2004151102 hasConcept C42219234 @default.
• W2004151102 hasConcept C71924100 @default.
• W2004151102 hasConcept C98274493 @default.
• W2004151102 hasConceptScore W2004151102C126322002 @default.
• W2004151102 hasConceptScore W2004151102C126894567 @default.
• W2004151102 hasConceptScore W2004151102C142724271 @default.
• W2004151102 hasConceptScore W2004151102C204787440 @default.
• W2004151102 hasConceptScore W2004151102C27081682 @default.
• W2004151102 hasConceptScore W2004151102C2778531004 @default.
• W2004151102 hasConceptScore W2004151102C2778689640 @default.
• W2004151102 hasConceptScore W2004151102C2910745098 @default.
• W2004151102 hasConceptScore W2004151102C42219234 @default.
• W2004151102 hasConceptScore W2004151102C71924100 @default.
• W2004151102 hasConceptScore W2004151102C98274493 @default.
• W2004151102 hasIssue "5" @default.
• W2004151102 hasLocation W20041511021 @default.
• W2004151102 hasLocation W20041511022 @default.

• next